Dynamic Diselenide Hydrogels for Controlled Tumor Organoid Culture and Dendritic Cell Vaccination

被引:0
|
作者
Han, Yueying [1 ]
Liu, Cheng [2 ]
Yin, Sheng [1 ]
Cui, Jian [1 ]
Sun, Yang [1 ]
Xue, Bin [1 ]
Jiang, Chunping [3 ,4 ]
Gu, Xiaosong [4 ]
Qin, Meng [1 ]
Wang, Wei [1 ]
Xu, Huaping [2 ]
Cao, Yi [1 ,4 ]
机构
[1] Nanjing Univ, Natl Lab Solid State Microstruct, Key Lab Intelligent Opt Sensing & Manipulat, Collaborat Innovat Ctr Adv Microstruct,Minist Educ, Nanjing 210093, Jiangsu, Peoples R China
[2] Tsinghua Univ, Dept Chem, Key Lab Organ Optoelect & Mol Engn, Beijing 100084, Peoples R China
[3] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Hepatobiliary Surg,Affiliated Hosp, Nanjing 210008, Jiangsu, Peoples R China
[4] Jinan Microecol Biomed Shandong Lab, Jinan 250021, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
dynamic diselenide bonds; tumor organoids; free radical storm; DC-based vaccines; immunotherapy; 3-DIMENSIONAL CULTURE; ADHESION; CADHERIN;
D O I
10.1021/acsami.4c18728
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Dynamic hydrogels are emerging as advanced materials for engineering tissue-like environments that mimic cellular microenvironments. We introduce a diselenide-cross-linked hydrogel system with light-responsive properties, designed for precise control of tumor organoid growth and light-initiated radical inactivation, particularly for dendritic cell (DC) vaccines. Diselenide exchange enables stress relaxation and hydrogel remodeling, while recombination and quenching of seleno radicals (Se center dot) reduce cross-linking density, leading to controlled degradation. We demonstrate a 2D to 3D growth strategy, where tumor cells inoculate on the hydrogel surface, expand, and gradually form spherical organoids within the 3D hydrogel. These tumor organoids show significantly higher drug resistance compared to 2D-cultured cells. High-density light irradiation enhances diselenide exchange, inducing hydrogel degradation, tumor cell death, and release of functional antigens. This system serves as a dynamic platform for tumor organoid culture and antigen release, offering significantly advanced approaches for in vitro tumor modeling and immunological research. Our findings position diselenide-cross-linked hydrogels as versatile materials for precision cellular engineering, with broad applications in cancer research and beyond.
引用
收藏
页码:69114 / 69124
页数:11
相关论文
共 50 条
  • [1] Dynamic bioengineered hydrogels as scaffolds for advanced stem cell and organoid culture
    Bahlmann, Laura C.
    Fokina, Ana
    Shoichet, Molly S.
    MRS COMMUNICATIONS, 2017, 7 (03) : 472 - 486
  • [2] Dynamic bioengineered hydrogels as scaffolds for advanced stem cell and organoid culture
    Laura C. Bahlmann
    Ana Fokina
    Molly S. Shoichet
    MRS Communications, 2017, 7 : 472 - 486
  • [3] Dendritic cell–tumor cell hybrid vaccination for metastatic cancer
    Jose Alexandre M. Barbuto
    Luis F. C. Ensina
    Andreia R. Neves
    Patrícia C. Bergami-Santos
    Katia R. M. Leite
    Ricardo Marques
    Frederico Costa
    Siderleny C. Martins
    Luiz H. Camara-Lopes
    Antonio C. Buzaid
    Cancer Immunology, Immunotherapy, 2004, 53 : 1111 - 1118
  • [4] Dendritic cell-tumor cell hybrid vaccination for metastatic cancer
    Barbuto, JAM
    Ensina, LFC
    Neves, AR
    Bergami-Santos, PC
    Leite, KRM
    Marques, R
    Costa, F
    Martins, SC
    Camara-Lopes, LH
    Buzaid, AC
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (12) : 1111 - 1118
  • [5] Dynamic matrices with DNA-encoded viscoelasticity for cell and organoid culture
    Peng, Y. -h.
    Hsiao, S. K.
    Gupta, K.
    Ruland, A.
    Auernhammer, G. K.
    Maitz, M. F.
    Boye, S.
    Lattner, J.
    Gerri, C.
    Honigmann, A.
    Werner, C.
    Krieg, E.
    NATURE NANOTECHNOLOGY, 2023, 18 (12) : 1463 - 1473
  • [6] Dynamic matrices with DNA-encoded viscoelasticity for cell and organoid culture
    Yu-Hsuan Peng
    Syuan-Ku Hsiao
    Krishna Gupta
    André Ruland
    Günter K. Auernhammer
    Manfred F. Maitz
    Susanne Boye
    Johanna Lattner
    Claudia Gerri
    Alf Honigmann
    Carsten Werner
    Elisha Krieg
    Nature Nanotechnology, 2023, 18 : 1463 - 1473
  • [7] Vaccination of renal cell cancer with tumor cell - dendritic cell hybrids.
    Stuhler, G
    Kugler, A
    Walden, P
    Zobywalski, A
    Kanz, L
    Ringert, RH
    CLINICAL CANCER RESEARCH, 2000, 6 : 4484S - 4484S
  • [8] Current status of dendritic cell-based-tumor vaccination
    Dannull, J
    Cerny, T
    Ackermann, DK
    Groettrup, M
    ONKOLOGIE, 2000, 23 (06): : 544 - 551
  • [9] Medullary thyroid carcinoma:: Autologous tumor cell lines for dendritic cell vaccination
    Pfragner, R
    Skofitsch, G
    Höger, H
    Jech, M
    Rinner, B
    Siegl, V
    Niederle, B
    Gnant, M
    Friedl, J
    Stift, A
    ANTICANCER RESEARCH, 2005, 25 (6B) : 4225 - 4230
  • [10] MEDULLARY THYROID CARCINOMAS: AUTOLOGOUS TUMOR CELL LINES FOR DENDRITIC CELL VACCINATION
    Pfragner, Roswitha
    Friedl, Josef
    Stift, Anton
    Niederle, Bruno
    Griant, Michael
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3599 - 3600